John Duncan Higgons

Insider Reports History

Entity
Individual
Location
C/O Agios Pharmaceuticals, Inc., 38 Sidney Street, 2 Nd Floor, Cambridge, MA
Signature
/s/ Caroline Gammill, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Duncan Higgons:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Jounce Therapeutics, Inc. Director Stock Option (Right to Buy) 20K Jun 24, 2022 Direct

Insider Reports Filed by John Duncan Higgons

Symbol Company Period Transactions Value $ Form Type Date Filed Role
JNCE Jounce Therapeutics, Inc. Jun 24, 2022 1 $0 4 Jun 28, 2022 Director
JNCE Jounce Therapeutics, Inc. Jun 18, 2021 1 $0 4 Jun 22, 2021 Director